Association between CLN3 (neuronal ceroid lipofuscinosis, CLN3 type) gene expression and clinical characteristics of breast cancer patients

dc.contributor.authorMakoukji, Joelle
dc.contributor.authorRaad, Mohamad A.
dc.contributor.authorGenadry, Katia Christina
dc.contributor.authorEl-Sitt, Sally Boulos
dc.contributor.authorMakhoul, Nadine J.
dc.contributor.authorSaad Aldin, Ehab
dc.contributor.authorNohra, Eden A.
dc.contributor.authorJabbour, Mark N.
dc.contributor.authorSangaralingam, Ajanthah
dc.contributor.authorChelala, Claude
dc.contributor.authorHabib, Robert H.
dc.contributor.authorBoulos, Fouad I.
dc.contributor.authorTfayli, Arafat Hussein
dc.contributor.authorBoustany, Rose Mary Naaman
dc.contributor.departmentBiochemistry and Molecular Genetics
dc.contributor.departmentInternal Medicine
dc.contributor.departmentPathology and Laboratory Medicine
dc.contributor.departmentClinical Research Institute
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T11:37:47Z
dc.date.available2025-01-24T11:37:47Z
dc.date.issued2015
dc.description.abstractBreast cancer is the most common cancer in women worldwide. Elucidation of underlying biology and molecular pathways is necessary for improving therapeutic options and clinical outcomes. CLN3 protein (CLN3p), deficient in neurodegenerative CLN3 disease is anti-apoptotic, and defects in the CLN3 gene cause accelerated apoptosis of neurons in CLN3 disease and up-regulation of ceramide. Dysregulated apoptotic pathways are often implicated in the development of the oncogenic phenotype. Predictably, CLN3 mRNA expression and CLN3 protein were up-regulated in a number of human and murine breast cancer-cell lines. Here, we determine CLN3 expression in non-tumor vs. tumor samples from fresh and formalin-fixed/paraffin-embedded (FFPE) breast tissue and analyze the association between CLN3 overexpression and different clinicopathological characteristics of breast cancer patients. Additionally, gene expression of 28 enzymes involved in sphingolipid metabolism was determined. CLN3 mRNA is overexpressed in tumor vs. non-tumor breast tissue from FFPE and fresh samples, as well as in mouse MCF7 breast cancer compared to MCF10A normal cells. Of the clinicopathological characteristics of tumor grade, age, menopause status, estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 (HER2), only absence of HER2 expression correlated with CLN3 overexpression. Sphingolipid genes for ceramide synthases 2 and 6 (CerS2; CerS6), delta(4)-desaturase sphingolipid 2 (DEGS2), and acidic sphingomyelinase (SMPD1) displayed higher expression levels in breast cancer vs. control tissue, whereas ceramide galactosyltransferase (UGT8) was underexpressed in breast cancer samples. CLN3 may be a novel molecular target for cancer drug discovery with the goal of modulation of ceramide pathways. © 2015 Makoukji, Raad, Genadry, El-Sitt, Makhoul, Saad Aldin, Nohra, Jabbour, Sangaralingam, Chelala, Habib, Boulos, Tfayli and Boustany.
dc.identifier.doihttps://doi.org/10.3389/fonc.2015.00215
dc.identifier.eid2-s2.0-84947078159
dc.identifier.urihttp://hdl.handle.net/10938/28873
dc.language.isoen
dc.publisherFrontiers Media S.A.
dc.relation.ispartofFrontiers in Oncology
dc.sourceScopus
dc.subjectBreast cancer
dc.subjectCeramide
dc.subjectCln3
dc.subjectHer2
dc.subjectSphingolipid signaling
dc.subjectBiological marker
dc.subjectEpidermal growth factor receptor 2
dc.subjectEstrogen receptor
dc.subjectGanglioside galactosyltransferase
dc.subjectMessenger rna
dc.subjectPhosphate
dc.subjectProgesterone receptor
dc.subjectPropidium iodide
dc.subjectSmall interfering rna
dc.subjectSphingomyelin phosphodiesterase d
dc.subjectTrypan blue
dc.subjectAdult
dc.subjectAged
dc.subjectApoptosis
dc.subjectArticle
dc.subjectBreast cancer cell line
dc.subjectBreast carcinoma
dc.subjectCancer patient
dc.subjectCancer staging
dc.subjectCln3 gene
dc.subjectControlled study
dc.subjectCytolysis assay
dc.subjectDna microarray
dc.subjectFemale
dc.subjectGene
dc.subjectGene overexpression
dc.subjectGene silencing
dc.subjectGenetic association
dc.subjectGenetic transfection
dc.subjectHistopathology
dc.subjectHuman
dc.subjectHuman cell
dc.subjectHuman tissue
dc.subjectMajor clinical study
dc.subjectMenopause
dc.subjectNeuronal ceroid lipofuscinosis
dc.subjectPhenotype
dc.subjectPremenopause
dc.subjectProtein expression
dc.subjectProtein protein interaction
dc.subjectReal time polymerase chain reaction
dc.subjectSphingolipid metabolism
dc.titleAssociation between CLN3 (neuronal ceroid lipofuscinosis, CLN3 type) gene expression and clinical characteristics of breast cancer patients
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2015-10273.pdf
Size:
5.95 MB
Format:
Adobe Portable Document Format